What is NDC 50090-3927?

50090-3927 is the product NDC for Doxazosin, Doxazosin mesylate 4 mg/1 tablet, listed with the FDA by A-S Medication Solutions. It has 3 package NDCs, shown above in 10- and 11-digit form.

A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Doxazosin?

106 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Doxazosin NDC 50090-3927 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-3927Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-3927Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
50090-3927-0	5009039270050090392700	30 TABLET in 1 BOTTLE (50090-3927-0)Marketed from Dec 7, 2018
50090-3927-1	5009039270150090392701	100 TABLET in 1 BOTTLE (50090-3927-1)Marketed from Dec 7, 2018
50090-3927-2	5009039270250090392702	90 TABLET in 1 BOTTLE (50090-3927-2)Marketed from May 10, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Doxazosin
Generic name (nonproprietary): doxazosin
Active ingredients: Doxazosin mesylate — 4 mg/1
Dosage form: Tablet
Route: Oral
Labeler: A-S Medication SolutionsNDC labeler code 50090
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208719
Marketing start: Aug 31, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)
Identifiers: Product ID 50090-3927_ab9e7c32-0e80-4871-bdb2-5190cc4fdd5fSPL ID ab9e7c32-0e80-4871-bdb2-5190cc4fdd5fSPL set ID 46b01b1d-c48a-4c36-bf3c-bba98066166cRxCUI 197627UNII 86P6PQK0MU
Pharmacologic class: alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090392700 followed by a unit qualifier and the quantity

Package 50090-3927-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 10, 2024.

Indications (excerpt from the label)

Doxazosin tablets are an alpha1 adrenergic antagonist indicated for: Signs and symptoms of Benign Prostatic Hyperplasia (BPH) Treatment of Hypertension 1.1 Benign Prostatic Hyperplasia (BPH) Doxazosin tablets are indicated for the treatment of the signs and symptoms of BPH. 1.2 Hypertension Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. Control of high blood pressure should be…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 50090-3927

What is NDC 50090-3927?: 50090-3927 is the product NDC for Doxazosin, Doxazosin mesylate 4 mg/1 tablet, listed with the FDA by A-S Medication Solutions. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Doxazosin.
What is the active ingredient?: Doxazosin mesylate.
Who is the labeler?: A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Doxazosin?: 106 other product NDCs are listed under this name. See all Doxazosin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Doxazosin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-166	16571-0166-01
Doxazosin	Doxazosin mesylate 1 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-165	16571-0165-01
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-167	16571-0167-01
Doxazosin	Doxazosin mesylate 8 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-168	16571-0168-01
Doxazosindoxazosin mesylate	Doxazosin mesylate 1 mg/1	TabletOral	Aurobindo Pharma Limited	59651-892	59651-0892-0159651-0892-99
Doxazosindoxazosin mesylate	Doxazosin mesylate 2 mg/1	TabletOral	Aurobindo Pharma Limited	59651-893	59651-0893-0159651-0893-99
Doxazosindoxazosin mesylate	Doxazosin mesylate 4 mg/1	TabletOral	Aurobindo Pharma Limited	59651-894	59651-0894-0159651-0894-99
Doxazosindoxazosin mesylate	Doxazosin mesylate 8 mg/1	TabletOral	Aurobindo Pharma Limited	59651-895	59651-0895-0159651-0895-99
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	REMEDYREPACK INC.	70518-4031	70518-4031-00
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	REMEDYREPACK INC.	70518-3965	70518-3965-0070518-3965-01

All 107 Doxazosin NDCs

Other NDCs under ANDA 208719

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208719
Product	Strength	Form · route	Labeler	Product NDC
Doxazosin	Doxazosin mesylate 1 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1112
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1114
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1113
Doxazosin	Doxazosin mesylate 8 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1115
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	Bryant Ranch Prepack	71335-2395
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	REMEDYREPACK INC.	70518-3965
Doxazosin	Doxazosin mesylate 8 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-831
Doxazosin	Doxazosin mesylate 1 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	68382-783
Doxazosin	Doxazosin mesylate 8 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	68382-786
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	68382-784
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	68382-785
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-4892
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	NuCare Pharmaceuticals, Inc.	68071-3811